Deals Of The Week: Adimab/Mersana, Merck Serono/Prexton, Idenix/Novartis
Executive Summary
Enlight’s latest portfolio company, KNODE, soon will launch a search and networking platform to help researchers locate information, identify experts and form communities.
You may also be interested in...
Prexton Therapeutics’ Parkinson’s Assets First to Emerge from Merck KGAA Restructuring
Prexton Therapeutics will be headquartered at the Eclosion incubator facility in Geneva and will advance mGluR compounds for Parkinson’s from the Merck Serono portfolio.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.